{
    "2021-11-29": [
        [
            {
                "time": "",
                "original_text": "贝达药业最新公告：贝伐珠单抗注射液获得药品注册证书",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "贝伐珠单抗",
                        "药品注册证书"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "重磅！贝达药业贝伐珠单抗注射液获批上市",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "贝伐珠单抗",
                        "获批上市"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：贝伐珠单抗注射液(MIL60)获得药品注册证书",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "贝伐珠单抗",
                        "MIL60",
                        "药品注册证书"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "益方生物8亿股权激励入研发费用",
                "features": {
                    "keywords": [
                        "益方生物",
                        "股权激励",
                        "研发费用"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "掘金创新药丨科伦药业子公司PD-L1抗体申报上市 康宁杰瑞已抢先一步获批",
                "features": {
                    "keywords": [
                        "科伦药业",
                        "PD-L1抗体",
                        "申报上市",
                        "康宁杰瑞",
                        "获批"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业创新药周报：OMICRON毒株异军来袭 新冠药物研发快速推进",
                "features": {
                    "keywords": [
                        "医药生物",
                        "创新药",
                        "OMICRON毒株",
                        "新冠药物研发"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}